LD TECHNOLOGY PRODUCT CATALOG

Similar documents
LD TECHNOLOGY PRODUCT CATALOG

EARLY DETECTION OF DIABETES COMPLICATIONS AUTONOMIC NERVOUS SYSTEM AND VASCULAR FUNCTION ASSESSMENTS

ARTERIAL STIFFNESS ASSESSMENT COMMENTS:

ANS1 : Sudopath & TM Oxi

SUMMARY REPORT. Autonomic Nervous System Function. Valsalva 100

Identifying Autonomic Neuropathy and Endothelial Dysfunction in Type II Diabetic Patients

QANS ASSESSMENT SYSTEM

RM-3A Cardiovascular & ANS Medical Device

ESTECK Status Report [Abridged]

Managing cardiovascular risk with SphygmoCor XCEL

World s Fastest Ankle-Brachial Index Screening Device

with SERIES ANALYTICAL SYSTEM Clinical, Billing & Orientation Reference Guide

VitalScan Plus. Autonomic Dysfunction Assessment. VitalScan + In 15 Minutes Identify Patients at Risk. Medeia Inc

Imaging for Peripheral Vascular Disease

World s Fastest Ankle-Brachial Index Screening Device

Managing anti-hypertensive treatment with SphygmoCor XCEL

boso Germany PAOD! The crucial Premium-quality risk marker for heart attack and stroke! Now PAOD screening with the boso ABI-system!

A Healthy Heart. IN BRIEF: Your Guide to

QANS ASSESSMENT SYSTEM

Cardiovascular Diseases in CKD

Blood Pressure Estimation Using Photoplethysmography (PPG)

Automated Blood Pressure Monitor

Our Vision NADA BoD Strategic Planning Session -

Utility of Exercise-Induced Zero TBI Sign in Patients on Maintenance Hemodialysis

Clinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy

Lower Extremity Arterial Disease

Peripheral Arterial Disease

boso Germany reliably boso Abi-system 100 Premium quality seen in time Arteriosclerosis and economically. PWV measurement option.

INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS

HRV in Diabetes and Other Disorders

Monitoring Equipment. Blood Pressure Monitor Upper Arm Type: Image (Image not to scale)

Arterial Age and Shift Work

Peripheral Arterial Disease Extremity

Copyright 2013 Renua Medical TM, A Health First Technologies, Inc. Company. All rights reserved.

BGmetrix 3000 Series

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

UC SF. Disclosures. Vascular Assessment of the Diabetic Foot. What are the best predictors of wound healing? None. Non-Invasive Vascular Studies

Diabetic Foot Ulcers. Alex Khan APRN ACNS-BC MSN CWCN CFCN WCN-C. Advanced Practice Nurse / Adult Clinical Nurse Specialist

Practical Point in Diabetic Foot Care 3-4 July 2017

Endothelial function is impaired in women who had pre-eclampsia

vasolab 320 Vascular Diagnosis Center

Non- invasive vascular testing. Pros and Cons of ABIs and Alternative Physiologic Assessments

boso ABI-system 100 inexpensive New feature: PWV Early detection of PAOD: fast, accurate The easy way of checking for measurement option

VITAL SIGNS MONITORING. RVS-100/200 ri-vital. Vital Signs Patient Monitors

Due to Perimed s commitment to continuous improvement of our products, all specifications are subject to change without notice.

EDUCATION. Peripheral Artery Disease

Heart Rate and Blood Pressure as Vital Signs

High Risk Podiatry in a Vascular Setting; A new paradigm in Diabetic Foot Disease? Ereena Torpey Senior Podiatrist - FMC

Measurement of Hemodynamic Parameters: Design of Methods and Hardware

Medical Electronics Dr. Neil Townsend Michaelmas Term 2001 ( The story so far.

iworx Sample Lab Experiment HC-5: Body Position, Exercise, and Cardiac Output

Coronary artery disease (CAD) risk factors

droxidopa (Northera )

Evidence of Baroreflex Activation Therapy s Mechanism of Action

/tj7-0zq0 510 (k) Summary P

What Is PAD? MAY SHOWERS, BRING SPRING FLOWERS! mhtml:file://c:\users\copper Moon Media\Documents\NMFA\newsletters\2017\May

MAX PULSE RESULT INTERPRETATION GUIDE PROVE CLINICAL EFFICACY IMPROVE CLINICAL OUTCOMES IMPROVE PATIENT ADHERENCE

Dopplex ABIlity Automatic Ankle Brachial Index System. Image

DON T LET LEG PAIN BECOME A REAL THREAT.

AFFORDABLE TECHNOLOGY

BackBeat Cardiac Neuromodulation Therapy (CNT) for Immediate, Substantial and Sustained Lowering of Blood Pressure. Daniel Burkhoff MD PhD

ASSESSING THE VASCULAR STATUS OF THE FEET FOR PATIENTS WITH DIABETES

Impedance Cardiography (ICG) Application of ICG for Hypertension Management

Estimation of Pulse Arrival Time Using Impedance Plethysmogram from Body Composition Scales

The Internist s Approach to Neuropathy

Biomedical Instrumentation E. Blood Pressure

Introduction of diverse devices to measure arterial stiffness

BP-600 Noninvasive Blood Pressure Sensor

Activity Vital Signs: Heart Rate and Blood Pressure

Keun-Ho Kim and Sang-Suk Lee* Department of Oriental Biomedical Engineering, Sangji University, Wonju , Korea

CHAPTER 4 ESTIMATION OF BLOOD PRESSURE USING PULSE TRANSIT TIME

Non-invasive examination

Automatic Ankle Brachial Index System. Image

Sympathetic Vasomotor Response Of The Radial Artery In Patients With End Stage Renal Disease

TODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients

8) BLOOD PRESSURE AND PULSE RATE RESPONSES TO SUSTAINED HANDGRIP DYNAMOMETER TEST IN RHEUMATOID ARTHRITIS PATENTS

Device Equivalence Evaluation Form

Objective assessment of CLI patients Hemodynamic parameters

AUTONOMIC FUNCTION IS A HIGH PRIORITY

Special Lecture 10/28/2012

Blood Pressure 1 of 22 Boardworks Ltd 2011

Q&A. DEMO Version

RM- 3A Full Report Review How to Use the 8 Risk Factors

RM-3A Clinical Diagnosis Reference Guide RM-3A Cardiovascular and ANS Medical Device

Clinical Study Of Autonomic Neuropathy In Diabetes Mellitus

Arterial stiffness index: A new evaluation for arterial stiffness in elderly patients with essential hypertension

boso ABI-system 100 Early detection of PAOD fast, precise, without Doppler Premium quality for doctors and hospitals

LAB 4. Human Cardiovascular Lab

Case Study: Chris Arden. Peripheral Arterial Disease

Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE

MEDICALSOFT. Innovative health & wellness screening systems for professional and personal use

Aortic and Iliac Artery Occlusive Disease (Updated 10.08)

Abstract. (Left Mouse-click to begin and move to next slide.)

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France

EARLY IDENTIFICATION AND FOLLOW-UP OF PERIPHERAL AUTONOMIC NEUROPATHIES

Anatomy, Biomechanics, Work Physiology, and Anthropometry. After completing and understanding of the current chapter students should be able to:

CAMOSUN COLLEGE BIOLOGY 144 (2010) LABS

Transcription:

LD TECHNOLOGY M A K I N G A D I F F E R E N C E EARLY DETECTION OF DIABETES COMPLICATIONS AUTONOMIC NERVOUS SYSTEM AND ARTERY ASSESSEMENT BLOOD PRESSURE AND ARTERIAL STIFFNESS ANALYSIS Monitoring and Treatment Management of Hypertension HEART RATE VARIABILITY (HRV) Cardiac Autonomic Dysfunction Assessment PHOTOPLETHYSMOGRAPHY Microcirculation disorders are the earlier stages of artery and Autonomic Nervous System complications CARDIAC AUTONOMIC REFLEX TESTS (CARTs) Cardiac Autonomic Neuropathy Assessment ANKLE BRACHIAL INDEX (ABI) Peripheral Artery Disease. Artery Blood Flow blockage or Calcification SUDOMOTOR FUNCTION TESTS Small Fiber Neuropathy Assessment LD TECHNOLOGY PRODUCT CATALOG

MAIN SYMPTOMS OF AUTONOMIC NERVE AND ARTERY DYSFUNCTION / DAMAGE Fatigue Headache Dizziness Exercice Intolarance Fainting Tingling in the Toes or Fingers Claudication Paintful muscle cramping in the hips, thighs or calves when walking, climbing stairs or exercising POPULATIONS THAT SHOULD BE TESTED WITH LD PRODUCTS Autonomic nerves and artery damage risk group in the USA 50+ 70+ Population over 50 years old with cardiovascular risk factors (Hypertensive, Overweight, Smoker, Diabetic) Everyone older than 70 OVER 45 MILLION PEOPLE EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH LD PRODUCTS

TM-FLOW ARTERY / AUTONOMIC NERVES ARTERY ASSESSMENT AUTONOMIC NERVOUS SYSTEM ASSESSMENT LD-OXY OXIMETER FEET ELECTRODES TM-F l ow is focused on th e a u t o n o m i c n e r vo us s ys t e m a n d v a sc u la r sy st em f o r t h e ea r ly d etec t i o n a n d mo n i t o r i n g of com pl ication s res ul ting from chronic dis ea s e s, s uc h a s Di a b e t e s. PATIENT SETUP

TM-FLOW MARKERS ARTERY ASSESSMENT : ANS ASSESSMENT : Photoplethysmography (PTG) analysis Volume plethysmography analysis Second derivative PTG Pulse Wave Velocity (PWV) Peripheral Augmentation Index (paix) Central Aortic Systolic Pressure (CASP) Ankle Brachial Indices (ABI) Toe Brachial Index (TBI) Sudomotor markers Peak sweat gland blood flow and density Heart Rate Variability Analysis (HRV) Total Power, SDANN, LF, HF and LF/HF Cardiac Autonomic Reflex Tests (CARTs) Valsalva Ratio, E/I Ratio, K30/15 Ratio and Systolic blood pressure response difference while standing MICROCIRCULATION DISORDERS X PERIPHERAL ARTERY DISEASE X SUDOMOTOR DYSFUNCTION X CARDIAC AUTONOMIC NEUROPATHY BENEFITS OF TM-FLOW SYSTEM No Human Error Clear report Accurate Results (Simultaneous measurements) 7-10 min ANS and Artery Overview Combinaison of Technologies TM-FLOW is the only available medical device for assessing the Autonomic Nervous System and Arteries in one simultaneous exam. It helps the physician to distinguish the cause of neuropathic or vascular symptoms. Although the symptoms may imitate each other, it is imperative to distinguish between Autonomic Neuropathy and Artery Disease because the treatments are quite different. TM-FLOW performs accurate, simultaneous measurements that are based on established medical guidelines without any extrapolation of the results.

TM-FLOW TECHNICAL SPECIFICATIONS TM-FLOW is a Medical Device Data System (MDDS) which manages the SweatC, TM-ABI and LD-OXY Systems. FDA product code: OUG. Measuring principle SWEATC Galvanic skin response Voltage Intensity Measuring Range Maximum 1.28 V Maximum 200 ma SWEATC (a.k.a.sudoc) Galvanic Skin Response related to the sweat gland function. Measuring Accuracy The max mean deviation ± 3% 510k # k152216 Power requirements Supply voltage 5V via USB port Measuring types Measuring ranges TM-ABI Ankle Brachial pressure index using volume plethysmography method for measuring systolic and diastolic pressure at arm and ankles. Pressure: 0 to 299 mmhg Heart rate 30 to 199 per min. TM-ABI Volume Plethysmography for assessing symtomatic peripheral artery disease. 510k # k143152 LD-OXY SpO₂ Parameter Specification Measuring range 0%~100% (the resolution is 1%) Measuring range Photoplethysmography resolution: 100 ms Pulse Parameter Specification Measuring ranges 30 bpm ~ 250 bpm, (the resolution is 1bpm) LD-OXY Photoplethysmography analysis, HRV and CARTs analysis. 510k # k160956 Accuracy ± 2bpm during the pulse rate range of 30 ~ 99bpm and 2% during pulse rate range of 100 ~ 250bpm

TM-ABI PLUS ARTERY PERIPHERAL ARTERY DISEASE ASSESSMENT The TM-ABI is the first valuable automated ankle-brachial index measuring system based on volume plethysmography for measuring blood pressure, ankle brachial and toe brachial index, arterial stiffness and central aortic Pressure. PATIENT SETUP

TM-ABI PLUS MARKERS ARTERY ASSESSMENT : Volume plethysmography analysis: Arm and Ankles Blood Pressure Pulse Wave Velocity (PWV) Peripheral Augmentation Index (paix) Central Aortic Systolic Pressure (CASP) Ankle Brachial Indices (ABI) Toe Brachial Index (TBI) PERIPHERAL ARTERY DISEASE BENEFITS OF TM-ABI PLUS No Human Error Clear report Accurate Results (Simultaneous measurements) 2-3 min ANS and Artery Overview Combinaison of Technologies TM-ABI PLUS detects all the markers of hypertension in addition to the Brachial Blood Pressure. The device provides Brachial and Ankle Arterial Stiffness and Central Aortic Systolic Pressure. ALLOWS NEW AND EFFECTIVE TREATMENT MANAGEMENT OF HYPERTENSION Best method to assess peripheral artery disease using: - Synchronization of the measurements arm-ankles - Blood pressure measurement from Photoplethysmography - Toe Brachial Index is a requirement to assess PAD in cases of ABI results >=1.4

TM-ABI PLUS TECHNICAL SPECIFICATIONS TM-ABI PLUS is a Medical Device Data System (MDDS) which manages the TM-ABI and LD-OXY Systems. FDA product code: OUG. TM-ABI Measuring types Measuring ranges Ankle Brachial pressure index using volume plethysmography method for measuring systolic and diastolic pressure at arm and ankles. Pressure: 0 to 299 mmhg Heart rate 30 to 199 per min. TM-ABI Volume Plethysmography for assessing symtomatic peripheral artery disease. 510k # k143152 LD-OXY SpO₂ Parameter Specification Measuring range 0%~100% (the resolution is 1%) Measuring range Photoplethysmography resolution: 100 ms Pulse Parameter Specification Measuring ranges 30 bpm ~ 250 bpm, (the resolution is 1bpm) LD-OXY Photoplethysmography analysis, HRV and CARTs analysis. 510k # k160956 Accuracy ± 2bpm during the pulse rate range of 30 ~ 99bpm and 2% during pulse rate range of 100 ~ 250bpm

ANS-1 AUTONOMIC NERVES AUTONOMIC NERVOUS SYSTEM ASSESSMENT OXIMETER FEET ELECTRODES ANS-1 system manages the Sudomotor test, Heart Rate Variability (HRV) Analysis at rest and during the Ewings tests in order to provide an overview of Automic nervous System. PATIENT SETUP

ANS-1 MARKERS ARTERY ASSESSMENT : ANS ASSESSMENT : Photoplethysmography (PTG) analysis Sudomotor function markers Conductance at anode and cathode following a DC stimulation Heart Rate Variability Analysis (HRV) Cardiac Autonomic Reflex Tests (CARTs) Valsalva Raio, E/I Ratio, K30/15 Ratio, Systolic response difference while standing MICROCIRCULATION DISORDERS X SUDOMOTOR DYSFUNCTION X CARDIAC AUTONOMIC NEUROPATHY BENEFITS OF ANS-1 No Human Error Clear report Accurate Results (Simultaneous measurements) 7-10 min ANS and Artery Overview ANS-1 System manages the Autonomic Nervous System battery of tests recommended by the American Academy of Neurology since 1996, and the Cardiovascular Autonomic Neuropathy Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy, for assessing the Autonomic Nervous System. Autonomic testing is recommended for all patients with type 2 diabetes at the time of the diagnosis, and 5 years after diagnosis in individuals with type 1 diabetes. ( Boulton et al., 2005;Tesfaye et al., 2010;Spallone et al., 2011; Bernardi et al.,2011.)

ANS-1 TECHNICAL SPECIFICATIONS ANS-1 is a Medical Device Data System (MDDS) which manages a unique Galvanic Skin response device, an oximeter and non-invasive blood pressure device. FDA product code: DXN, DQA, GZO and MNW. GALVANIC SKIN RESPONSE Measuring principle Galvanic skin response Measuring Range Voltage Intensity Maximum 1.28 V Maximum 200 ma Measuring Accuracy The max mean deviation ± 3% Power requirements Supply voltage 5V via USB port BLOOD PRESSURE DEVICE Measuring types Ankle Brachial pressure index using oscillometric method. Measuring ranges Pressure: 0 to 299 mmhg. ANS-1 SYSTEM Sudomotor function, HRV and CARTs Analysis and Photoplethysmography 510k # k140412 OXIMETER SpO₂ Parameter Specification Measuring range Measuring range 0%~100% (the resolution is 1%) Photoplethysmography resolution: 100 ms Pulse Parameter Specification Measuring ranges Accuracy 30 bpm ~ 250 bpm, (the resolution is 1bpm) ± 2bpm during the pulse rate range of 30 ~ 99bpm and 2% during pulse rate range of 100 ~ 250bpm

LD TECHNOLOGY M A K I N G A D I F F E R E N C E LD TECHNOLOGY ISO 13485-2003 - CAMCAS FDA OWNER/OPERATOR NUMBER: 9097859 FDA ESTABLISHMENT REGISTRATION NUMBER: 3006146787 CONTACT LD TECHNOLOGY +1 305 397 9900 www.ldteck.com ADDRESS 100 N. BISCAYNE BLVD, SUITE 502 33132 MIAMI, FLORIDA UNITED STATES